|
SUCLA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.970100E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.737700E-02 |
| Stage1-vs-Stage3 |
4.340000E-02 |
| Stage1-vs-Stage4 |
5.183200E-03 |
| Stage2-vs-Stage3 |
1.378910E-03 |
| Stage2-vs-Stage4 |
1.358640E-04 |
| Stage3-vs-Stage4 |
2.375800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.46809999951914E-07 |
| Normal-vs-Asian |
1.86439752525303E-12 |
| Caucasian-vs-AfricanAmerican |
1.391250E-01 |
| Caucasian-vs-Asian |
9.192800E-01 |
| AfricanAmerican-vs-Asian |
2.061800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.657440E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(61-80Yrs) |
1.63846713974181E-12 |
| Normal-vs-Age(81-100Yrs) |
1.51849999996401E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.647000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.735600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.909000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.796000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.833200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.679800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.944600E-03 |
| Classical-VS-Follicular |
9.98110000000052E-05 |
| Classical-VS-Other |
6.495400E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
8.43240000047984E-08 |
| Tall-VS-Other |
4.101800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.178980E-01 |
| Follicular-VS-Normal |
1.52064999999757E-05 |
| Other-VS-Normal |
4.01540000000145E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.30926389122033E-14 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.416990E-03 |
|
|
